Roche Glycart AG
... generations of engineered antibody products with increased efficacy that address unmet clinical needs. The ... generations of engineered antibody products with increased efficacy that address unmet clinical needs. The ...
ImmunOs Therapeutics AG
... novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and ... novel immunotherapies that enhance the efficacy of market leading checkpoint inhibitors and ...
InCephalo AG
... regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce ... regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce ...
Elecsys® Anti-HBs II
... ). Hepatitis B vaccines: protective efficacy and therapeutic potential. Pathol Biol (Paris) 58, 288-295 ... . Michel, M.L., Tiollais, P. (2010). Hepatitis B vaccines: protective efficacy and therapeutic potential ...
Elecsys® NT-proBNP
... 71, 1191-1200 Taylor et al. (2017). Efficacy and Mechanism Evaluation, No. 4.3. National Institute ... . (2017). Efficacy and Mechanism Evaluation, No. 4.3. National Institute for Health Research. ISSN 2050 ...
